Search clinical trials for: PSMA-Low Castration Resistant Prostate Cancer
Total 90023 results
-
University Hospital TuebingenGerman Cancer Research CenterRecruitingCastration-Resistant Prostatic CancerGermany
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Prostate Cancer Foundation; Madison Vaccines, IncRecruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate CancerUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerCanada
-
National Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Lymph NodesUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
British Columbia Cancer AgencyRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Canada
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Institute of Cancer Research, United KingdomProstate Cancer UKRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerUnited Kingdom
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Hinova Pharmaceuticals Inc.Recruiting
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Tianjin Medical University Second HospitalRecruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticChina
-
Allife Medical Science and Technology Co., Ltd.Tianjin People's HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Rahul AggarwalAstraZenecaRecruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Endometrial Cancer | Stage III Renal Cell Cancer | Locally Advanced Malignant Solid Neoplasm | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Stage IV... and other conditionsUnited States
-
Technical University of MunichRecruitingCastration-resistant Prostate CancerGermany
-
CellCentric Ltd.RecruitingAdvanced Solid Tumors | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Metastatic Castration-Resistant Prostate CancerUnited Kingdom, United States, Netherlands, France, Spain, Sweden
-
St Vincent's Hospital, SydneyRecruitingCastration-resistant Prostate Cancer | Homologous Recombination DeficiencyAustralia
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
PfizerRecruitingSmall Cell Lung Cancer (SCLC) | Follicular Lymphoma (FL) | Castration Resistant Prostate Cancer (CRPC)United States, Spain, Korea, Republic of, Poland, China, Bulgaria, Russian Federation, Japan
-
University of RochesterRoswell Park Cancer InstituteRecruiting
-
Istituto Scientifico Romagnolo per lo Studio e...BayerRecruitingMetastatic Castration-resistant Prostate CancerItaly
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Astex Pharmaceuticals, Inc.; Institute of Cancer Research...RecruitingNon Small Cell Lung Cancer | Castration-Resistant Prostatic CancerUnited Kingdom
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer Patients With OligometastasesCanada
-
Aragon Pharmaceuticals, Inc.RecruitingProstatic Neoplasms, Castration-ResistantMoldova, Republic of, Spain
-
Indiana UniversityRecruitingTraumatic Brain InjuryUnited States
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, Australia, France, Germany, United Kingdom, Belgium, Spain, Argentina, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Mexico
-
Arcus Biosciences, Inc.CompletedMelanoma | Renal Cell Carcinoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Castration-resistant Prostate Cancer | Merkel Cell Carcinoma | GastroEsophageal CancerUnited States, Australia
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
-
Janssen Research & Development, LLCActive, not recruitingProstatic Neoplasms, Castration-ResistantBelgium, United States, United Kingdom, Canada, Israel, Spain, Italy
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Stand Up To Cancer; High Impact Clinical Research Support...Completed
-
Aragon Pharmaceuticals, Inc.Active, not recruiting
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Janssen Research & Development, LLCActive, not recruitingNeoplasmsCanada, Israel, Spain
-
Janssen Research & Development, LLCActive, not recruiting
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Janssen Research & Development, LLCActive, not recruiting
-
Massachusetts General HospitalActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; PfizerActive, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Sichuan UniversityEnrolling by invitationMetastatic Prostate CancerChina
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaActive, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerJapan
-
Coherus Biosciences, Inc.Arcus Biosciences, Inc.; Surface OncologyTerminatedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Canada
-
Bristol-Myers SquibbActive, not recruitingProstate CancerRomania, United States, Israel, Russian Federation, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Puerto Rico, Singapor... and more